Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 23, 2026.

Gene Editing and Crop Improvement Using CRISPR-Cas9 System

Leena Arora, Alka Narula

Frontiers in Plant Science · 2017 · Review

doi:10.3389/fpls.2017.01932

Abstract

Advancements in Genome editing technologies have revolutionized the fields of functional genomics and crop improvement. CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat)-Cas9 is a multipurpose technology for genetic engineering that relies on the complementarity of the guideRNA (gRNA) to a specific sequence and the Cas9 endonuclease activity. It has broadened the agricultural research area, bringing in new opportunities to develop novel plant varieties with deletion of detrimental traits or addition of significant characters. This RNA guided genome editing technology is turning out to be a groundbreaking innovation in distinct branches of plant biology. CRISPR technology is constantly advancing including options for various genetic manipulations like generating knockouts; making precise modifications, multiplex genome engineering, and activation and repression of target genes. The review highlights the progression throughout the CRISPR legacy. We have studied the rapid evolution of CRISPR/Cas9 tools with myriad functionalities, capabilities, and specialized applications. Among varied diligences, plant nutritional improvement, enhancement of plant disease resistance and production of drought tolerant plants are reviewed. The review also includes some information on traditional delivery methods of Cas9-gRNA complexes into plant cells and incorporates the advent of CRISPR ribonucleoproteins (RNPs) that came up as a solution to various limitations that prevailed with plasmid-based CRISPR system.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 23, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Genetic diversity is a key source for trait improvement in plants. Creating variations in the gene pool is the foremost requirement for developing novel plant varieties. Once the desired alterations are achieved, transgenes can be crossed out from the improved variety. Crop improvement has been done for years via traditional plant breeding techniques or through various physical, chemical (e.g., gamma radiation, ethyl methanesulfonate) and biological methods (e.g., T-DNA, transposon insertion) leading to point mutations, deletions, rearrangements, and gene duplications. The advent of site-specific nucleases (SSNs) highlighted the importance of site directed mutagenesis over random mutagenesis. Random mutagenesis has also its own list of shortcomings too. It produces multiple undesirable rearrangements and mutations, which are expensive and very complex to screen. Gene editing uses engineered SSNs to delete, insert or replace a DNA sequence. Development of the engineered endonucleases/mega-nucleases, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and type II clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) paved the way for single nucleotide excision mechanism for crop improvement (Figure 1). These genome-editing technologies use programmable nucleases to increase the specificity of the target locus.

Genome editing modifies a specific genome in precise and predictable manner. There could be varieties of genes, which could be altered in different cell types and organisms with the aid of nucleases that offer targeted alterations. ZFNs is one of the oldest gene editing technologies, developed in the 1990s and owned by Sangamo BioSciences. ZFNs are premeditated restriction enzymes having sequence specific DNA binding zinc finger motifs and non-specific cleavage domain of Fok1 endonuclease. An array of 4–6 binding modules combines to form a single zinc finger unit. Each module recognizes a codon. A pair of ZFNs together identifies a unique 18–24 bp DNA sequence and double stranded breaks (DSBs) are made by Fok1 dimer. FokI nucleases are naturally occurring type IIS restriction enzymes that introduce single stranded breaks in a double helical DNA. Hence FokI functions as a dimer, with each catalytic monomer (nickase) cleaving a single DNA strand to create a staggered DSB with overhangs. ZFNs have been successfully employed in genome modification of various plants including tobacco, maize, soybean, etc.. It was taken back due to some drawbacks such as time-consuming and expensive construction of target enzymes, low specificity and high off-target mutations that eventually made way for the new technology. TALENs turned out to be a substitute to ZFNs and were identified as restriction enzymes that could be manipulated for cutting specific DNA sequences. Traditionally, TALENs were considered as long segments of transcription activator-like effector (TALE) sequences that occurred naturally and joined the Fokl domain with carboxylic-terminal end of manipulated TALE repeat arrays. TALENs contain a customizable DNA-binding domain which is fused with non-specific Fokl nuclease domain. TALENs compared to ZFNs, involve the interaction of individual nucleotide repeats of the target site and amino acid sequences of TAL effector proteins. They can generate overhangs by employing Fokl nuclease domain to persuade site-specific DNA cleavage. It has been widely used to generate non-homologous mutations with higher efficiencies in diverse organisms.

The emergence of CRISPR technology supersedes ZFNs and TALENs and used widely as a novel approach from “methods of the year” in 2011 to “breakthrough of the year” in 2015 for their captivated genome editing. This prokaryotic system is promptly accepted for genome editing in eukaryotic host cells. CRISPR has an added advantage of gene knockout over RNAi, which is a well-known technique for gene knockdown. CRISPR targets the endogenous genes that are impossible to specifically target using RNAi technology with more precision and simplicity. RNAi gene regulation is governed by the endogenous microRNAs (miRNAs). Any displacement of these miRNAs from the exogenous miRNAs can lead to hypomorphic mutations and off-target phenotypes. CRISPR/Cas9 targets specific genomic loci with the help of ∼100 nucleotide (nt) guide RNA (gRNA) sequence. sgRNA binds to the protospacer adjacent motif (PAM) on targeted DNA via Watson and Crick base pairing through 17–20 nt at the gRNA 5′-end and guide Cas9 for specific cleavage. Cas9 stimulates the DNA repair mechanism by introducing DSBs in the target DNA. Repair mechanism involves error prone non-homologous end joining (NHEJ) or homologous recombination (HR) to produce genomic alterations, gene knockouts and gene insertions (Figure 2). NHEJ by far is the most common DSB repair mechanism in somatic plant cells. Random insertions or deletions by NHEJ in the coding region lead to frame shift mutations, hence creating gene knockouts. CRISPR technology holds potential for loss-of-function, gain-of-function, and gene expression analysis. CRISPR has versatile applications in plant biology and is readily applied to produce high quality agriculturally sustainable products (Table 1). There are many plants which are in the process of getting altered through CRISPR/Cas9. The CRISPR edited tomatoes will be expected to have enhanced flavor, sugar content and aroma as compared to modern commercial varieties; corn is made resistant to drought with high yield per hectare; wheat is edited against powdery mildew disease, and mushrooms are targeted to reduce the melanin content.

CRISPR/Cas9 System

CRISPR progress in today’s world as genome editing tool can be traced back to its origin in the late 1980s and a decade of extensive experimentation since 2005 (Figure 3). CRISPR/Cas9 microbial adaptive immune system and its progress till date is the outcome of the work of numerous researchers around the globe. A series of comprehensive reviews gives the detailed information of each aspect of CRISPR/Cas technology.

Deciphering the role of CRISPR/Cas system in bacteria and archaea elucidated the power of this system as a genome-editing tool. A series of experiments involving bioinformatic tools unveiled various CRISPR/Cas components and their function in providing adaptive immunity to bacterial cells. A CRISPR locus consists of clusters of CRISPR-associated (Cas) genes and CRISPR arrays where all immunological memories are engraved. CRISPR array is a genomic locus having series of 21–40 bp repeat sequences (direct repeats) interspaced by 25–40 bp variable sequences (spacers). In 2005, three independent research groups hypothesized the role of spacer elements as traces of past invasions of foreign DNA that provide immunity against phage infection. They also noted that spacers share a common end sequence, now known as PAM. experimentally demonstrated the involvement of CRISPR arrays in resistance to bacteriophages in association with Cas genes. At every infection, new phage DNA gets incorporated into the CRISPR array building potential to fight the upcoming infection. Studies from unveil the transcription of phage spacer sequences into small RNAs (crRNAs) that guide Cas proteins to the target DNA. The mechanism of interference based on RNA-mediated DNA targeting and the role of Cas9 in introducing DSBs at a precise position, three nucleotides upstream of PAM was also demonstrated. Further a trans-activating CRISPR RNA (tracrRNA) forms a duplex with crRNA and guides Cas9 to its target. Fusion of the crRNA and tracrRNA to form a single, synthetic guide RNA further simplified the system. Finally, reported the ability of Cas9 to facilitate homology directed repair with minimum mutagenic activity.

Classification of CRISPR/Cas9 System

The first attempt to classify CRISPR/Cas system was done by. He defined 45 CRISPR-associated (Cas) protein families that are categorized into core proteins (Cas1, Cas2, Cas3, Cas4, Cas5, Cas6), 8 CRISPR/Cas subtypes and RAMP (repair associated mysterious protein) module in prokaryotic genomes. classified CRISPR/Cas systems into three types: type I, type II, and type III depending on the presence of signature Cas3, Cas9 and Cas10 proteins, respectively (Table 2). This system was divided into 10 subtypes depending on the presence of additional signature proteins. This three-type classification system is further modified into two class-five type classification systems depending on the type of signature proteins and CRISPR loci. Major differences between CRISPR classes are based on the composition of crRNP complexes. Class 1 CRISPRs have multiple subunit effector complexes while class 2 CRISPRs concentrates most of their functions with single protein effectors. Class 1 CRISPR system, for example, have different nucleases for pre-crRNA processing, spacer sequence loading, and targeted cleavage processing. In class 2, a single protein performs all of these functions. Type IV and type V belongs to class I and class II systems respectively. Two subtypes of type V system and VI type is also recognized, elaborating the classification to two-class–six-type–19-subtype system (; Table 2). Cas1 and Cas2 genes are ubiquitous in all CRISPR/Cas types.

CRISPR-Cpf1 (Class II, Type V CRISPR from Prevoltella and Francisella1) is an advanced tool that uses a single Cpf1 protein for crRNA processing, target site recognition, and DNA cleavage. Cpf1 is functionally conserved to Cas9 protein but differs substantially in many aspects. The differences are as follows: it is a ribonuclease that processes precursor crRNA; it recognizes a thymine rich (like 5′-TTTN-3′) PAM sites. PAM sequence is located upstream of the protospacer sequence and tracrRNA is not required for guiding Cas9 to the target site. The most important characteristic of Cpf1 is the generation of 4 bp overhangs in contract to blunt ends produced by Cas9. These sticky ends would provide more efficient genomic insertions due to sequence complementarity into a genome. Among several proteins in the Cpf1 family, LbCpf1 from Lachnospiraceae bacterium ND 2006 and AsCpf1 from Acidaminococcus sp. BV3L6 act more effectively in human cells compared with other orthologs. Class 2 type VI is characterized by an effector protein C2c2 (Class 2, candidate 2). C2c2 contains two nucleotide binding (HEPN) conserved domains, which lacks homology to any known DNA nuclease. HEPN domains function as RNases, hence it is visualized as a new RNA targeting tool guided by a single crRNA which can be engineered to cleave ssRNA carrying complementary protospacers. Hence, C2c2 does not target DNA. C2c2 is similar to type III-A and III-B systems in having HEPN domains that are biochemically characterized as ssRNA specific endoribonucleases but there is a significant line of difference between these two types. Cas10- Csm in type IIIA and Csx in type III B have less target specificity and have to dimerize to form active sites. C2c2, in contrast, contains two HEPN domains and function as monomeric endoribonuclease. dCas9 analogs of C2c2, dC2c2 can be produced by alanine substitution of any of the four predicted HEPN domain. Further examination is required to clarify the mechanism of the C2c2 system and the class of pathogens against which it can protect bacteria. Currently, type VI system is found in Carnobacterium gallinarum, Leptotrichia buccalis, L. shahii, L. wadei, Listeria newyorkensis, L. seeligeri, L. weihenstephanensis, Paludibacter propionicigenes, and Rhodobacter capsulatus.

CRISPR/Cas9 Mechanism

The adaptive immunity of CRISPR/Cas9 system consists of three phases: adaptation, expression, and interference (Figure 4). Adaptation involves the invading DNA from virus or plasmids that are cleaved into small fragments and incorporated into CRISPR locus. CRISPR loci are transcribed and processed to generate small RNA (crRNA), which guide the effector endonucleases to target the viral material by base complementarity. DNA interference in Type II CRISPR/Cas system requires a single Cas9 protein. Cas9 is a huge protein possessing multiple domains (RuvC domain at the amino terminus and the HNH nuclease domain positioned in middle) and two small RNAs namely crRNA and tracrRNA. Cas9 assists adaptation, participates in pre-crRNA processing to crRNA and introduce targeted DSBs guided by tracrRNA and double stranded RNA specific RNase III. As compared to type II CRISPR, the unique features of type III CRISPR are the cleavage of both DNA and RNA, and its association with the cleavage protein Cas10. The cleavage is a transcription-dependent DNA sequence modification that also contains a transcriptionally active promoter. Cas10 system enables bacteria to acquire viral spacer elements enabling a type of resistance against foreign DNA under special conditions. This resistance to foreign/viral DNA prevents activation of the lytic pathway, which is detrimental to the host cell. These sequences could also alter the physical characteristics of the cell, potentially providing a survival advantage for the host cell.

Multiplex genome engineering using multiple guide RNAs to target various genomic sites simultaneously was also demonstrated. CRISPR was first applied in plants in August 2013. targeted various endogenous genes and transgenes by protoplast transfection, agroinfiltration and generated stable transgenic plants by both NHEJ and HR mechanisms. Various genes leading to phenotypic variations were targeted like Brassinosteroid Insensitive 1 (BRI1), Jasmonate-Zim-Domain Protein 1 (JAZ1) and Gibberellic acid insensitive (GAI) in Arabidopsis and Rice Outermost Cell-specific gene5 (ROC5), Stromal Processing Peptidase (SPP), and Young Seedling Albino (YSA) in rice and obtained positive results. Similarly, introduced three guide RNAs at distinct rice genomic loci and analyzed the mutation efficiency of 3–8%. Off target mutations were also noticed but with minimum genome editing efficiency than the matched site.

Studies on maize, wheat, and sorghum provided an excellent foundation for the use of CRISPR in gene editing. These investigations postulated the first comprehensive data on parameters such as mutation efficiency, cleavage specificity, large chromosomal deletions and resolution of locus structure. also demonstrated the expression of gRNAs under the control of multiple promoters. emphasized the use of both CRISPR/Cas based nucleases and nickases with their studies conducted on Arabidopsis thaliana. Nucleases are efficient tools for NHEJ mediated mutagenesis and the combined action of two nickases can enhance recombination between tandemly arranged direct repeats, gene conversion guided by inverted repeats and can regulate mechanisms involving HR. Single chimeric gRNA are found to be more efficient than individual crRNA and tracrRNA components. Interestingly, four independent groups have demonstrated the introduction of biallelic or homozygous mutations in T1 generation of rice and tomato indicating the high efficiency of this system. The genetic changes are segregated normally in subsequent generations without further modifications. Some examples of the CRISPR/Cas9 applications in plants are cited in Table 1.

CRISPR/Cas9 system is continuously being upgraded for better efficiency and specificity of gene targeting. The need for repurposing CRISPR/Cas9 system to alter eukaryotic genome has necessitated the addition of nuclear localization signals at one or both ends of the protein. The introduction of orthogonal CRISPR/Cas9 systems has broadened the application of this technology manifold. These orthologs include RNA guided endonucleases from Streptococcus thermophilus (St), Neisseria meningitidis (Nm), Campylobacter jejuni (Cj), and Staphytococcus aureus (Sa). Each orthogonal Cas9 system has unique specifications including variations in Cas9 proteins, PAM sites and gRNA scaffolds for target recognition (Table 3). demonstrated efficient targeting of endogenous genes in human pluripotent stem cells via NmCas9. They are the pioneers in the development of NmCas9 that uses 24-nucleotide (nt) protospacer to target DNA over 20 nt protospacer requirements of SpCas9 and StCas9. Extended PAM sequence (5′-NNNNGATT-3′) as compared to NGG sequence may further enhance the specificity.

CRISPR Specifications in Plants

Efficient CRISPR/Cas9 genomes editing in plants require suitable vector system (codon optimized Cas9 gene and promoters for Cas9 and sgRNA), efficient target sites and transformation method used in appropriate plant species. CRISPR editing requires the delivery and expression of single guide RNA (sgRNA) and cas9 protein in the target cell. Specific expression vectors are designed to achieve this goal. sgRNA is generally regulated by tissue specific RNA polymerase III promoters such as AtU6, TaU6 etc. that drives the expression of small RNAs in their respective species. Similarly, Cas9 is placed downstream of RNA polymerase II promoters like ubiquitin promoters that guide the expression of longer RNAs. Cas9 is generally tagged with nuclear localization sequence (NLS) to target nuclear DNA. The choice of the vectors largely depends upon the type of the expression system to be worked on, type of restriction sites present to insert sgRNA and the type of Cas9 system. Both sgRNA and Cas9 can be co-expressed in a single plasmid ex. pFGC-pcoCas9, pRGEB32, pHSE401. Different types of plasmids can be studied from https://www.addgene.org/crispr/plant/. The use of these plasmids is limited depending upon the type of Cas9 (cut, nick, activate, interfere) present (Table 4).

Independent sgRNA plasmids are also designed where Cas9 is not co-expressed but can be paired along enabling usage of the wide variety of Cas9 types. pICSL01009::AtU6p and pICH86966::AtU6p::sgRNA_PDS which encodes an Arabidopsis U6 promoter and expresses sgRNA targeting PDS in Nicotiana benthamiana. The choice of the optimal promoters to drive the expression of sgRNA or Cas9 and codon optimized version of Cas9 is important for efficient genome editing. Most of the work in eukaryotic cells is done using codon optimized versions of SpCas9. Results have been obtained using human codon optimized or plant codon optimized versions of Cas9. The mutations induced can be heterozygous, biallelic (two distinct allelic mutations), homozygous or rarely chimeric. A number of reports confirmed the stable inheritance of CRISPR/Cas9 induced mutations in model and crop plants. Efficient CRISPR/Cas9 genome editing and inheritance of modified genes in the T3 and T2 generations was reported for the first time in Arabidopsis. A change in non-functional GFP gene was observed in T1 generation. All GFP-positive transgenic plants were identified with mutagenized GFP genes. Out of 42 transgenics developed, 50% have inherited a single T-DNA insert.

The general methodology for implementing targeted mutagenesis using CRISPR/Cas9 technology is outlined in Figure 5. It starts with the selection of specific target site having a short PAM sequence at 3′ end. Target site should be selected considering minimum or no off-target effects (preventing cuts at unintended sites in the genome). Many bioinformatics tools help in designing sgRNA with high specificity and detection of off-targets such as COSMID (CRISPR Off-target Sites with Mismatches, Insertions, and Deletions). Off-targets are more prevalent in bacterial and cultured mammalian cells than in plant cells. Many studies have shown the potential off-targets of cas9 such as, in soybean, the off-target frequency was found to be 13%. No detectable off-targets are found in A. thaliana, wheat, rice and sweet orange. Cas9 nickase has also emerged as an alternative to reduce off target effects. Nickase is guided by the sgRNA at two adjacent positions at the target site producing a single stranded break on each of the two DNA strands.

CRISPR-PLANT is a newly designed web portal supported by PennState and Arizona Genomics Institute (AGI) established to help researchers to use the CRISPR-Cas9 system for genome editing. It estimates the highly specific sgRNA by avoiding off-target sequences. After the target site confirmation, target specific oligonucleotides (20 nt) are designed which further fuses with tracrRNA sequence to form sgRNA. sgRNA is further placed in a vector either along with Cas9 sequence (a binary vector) or individually under a suitable promoter for an optimal expression. The constructs are then transformed using a suitable method. The delivery systems vary based on plant species, research purpose, and requirements. F gRNA-Cas9 mediated editing can be detected by a restriction enzyme digestion suppressed PCR (RE-PCR) method, which investigates the NHEJ-introduced mutations. RE-qPCR can also be performed for more accurate estimation of genome-editing efficiency. Finally, whole genome sequencing is done to reduce off-target modifications.

Targeted Genome Modification in Crop Plants

Over the years the biotic (bacteria, fungi, insects, and viruses) and abiotic (salinity, drought, flooding, heavy metal toxicity, high temperature) stresses have adversely affected crop plantation. One of the current researches in plant biology focuses on generating crops to tolerate harsh agro climatic conditions and to meet the needs of the ever-growing human race.

Genome Modification for Nutrition Improvement

CRISPR/Cas9 system can generate stable and heritable mutations without affecting the existing valuable traits. This results in the development of homozygous modified transgene free plants in only one generation and it’s stable transmission to successive generations. Cas9 continued to be a better tool with relatively high cleavage efficiency when compared to TALENs and ZFNs. Researches done on various crops since the advent of CRISPR technology in the plant world is highlighted in Table 1. Classic works are being done for producing acrylamide free potatoes, non-browning apples, mushrooms and potatoes by mutating Polyphenol oxidase (PPO) genes and low phytic acid in maize.

pioneered the work of targeted genome editing in sweet orange using Cas9/sgRNA. Genetic improvement of citrus is limited due to its slow growth, pollen incompatibility, polyembryony, and parthenocarpy. Xcc (Xanthomonas citri subsp. citri)-facilitated agroinfiltration was employed to deliver Cas9 and CsPDS gene specific sgRNA into sweet orange. DNA sequencing confirmed the mutated CsPDS gene at the target site with a mutation rate of 3.2 to 3.9%. No off-target mutagenesis was reported. targeted multicopy genes in Hordeum vulgare investigating the use and target specificity requirements of Cas9 editing. HvPM19 gene encoding an ABA-inducible plasma membrane protein was targeted to study the characteristics of dormancy. T0 were phenotypically identified with expected dwarf phenotype associated with a knockout of the target gene. discussed the presence of anti nutritional compound Phytic acid (PA), inositol 1,2,3,4,5,6-hexakisphosphate in maize. PA is poorly digested in humans and posses a threat to the environment, thus, PA content of maize seeds was reduced by designing two gRNAs targeting the ZmIPK (Inositol Phosphate Kinase) gene that catalyzes a key step in PA biosynthetic pathway.

Biotic and Abiotic Stress Resistance via CRISPR/Cas9

Multiple disease resistance plants have been obtained using CRISPR/Cas9 technology (Table 5). Some highlights involve the resistance against rice blast disease by targeting OsERF922 gene in rice. Transgene free mutant lines from T1 and T2 generations were selected by segregation and further examined. Transgenic lines showed a significant reduction blast lesions formed due to pathogen infection. introduced mutations using site-specific endonucleases in homeoalleles encoding Mildew-resistance locus (MLO) proteins of hexaploid bread wheat. targeted citrus canker caused by Xanthomonas citri subsp. Xcc in Citrus sinensis. CRISPR/Cas9 targeted modification of the susceptibility gene Lateral organ boundaries 1 (CsLOB1) promoter enhances disease resistance. Deletion of the entire EBEPthA4 sequence from both CsLOB1 alleles conferred the highest level of resistance to Wanjincheng orange. All transformed plants were morphologically similar to wild type indicating that CsLOB1 promoter modification does not disrupt plant development. 42% of the mutant plants harbored desired mutations and 23.5% of the mutants showed resistance to citrus canker. The stacking up of multiple nucleases as one transgene by CRISPR/Cas9 system also leads to the targeted cleavage of multiple infections by viruses.

CRISPR System in Metabolic Engineering

Further applications of CRISPR/Cas9 include extensive research in the field of metabolic engineering where plant cells are targeted for production of specific metabolites. manipulated the biosynthesis of benzylisoquinoline alkaloids (BIAs) for next generation metabolic engineering in Papaver somniferum by knocking out 3′ OMT2 gene via NHEJ DNA repair CRISPR/Cas9 mechanism. 4′ OMT2 (4′-O-methyltransferase) is a regulatory gene involved in the biosynthesis of codeine, noscapine, papaverine, and morphine via different BIA pathways. Such strategies can be employed to convert valuable medicinal plants into biofactories for mass production of specific metabolites simply by introducing breaks in related gene sequencing. targeted diterpene synthase gene (SmCPS1), involved in tanshinone biosynthesis in Salvia miltiorrhiza, Chinese herb well-known for vasorelaxation and antiarrhythmic effects. SmCPS1 is the entry enzyme that uses GGPP (geranylgeranyl diphosphate) as its substrate for generating tanshinones. GGPP also acts as a precursor for taxol biosynthesis, therefore; SmCPS1 knockout (post-GGPP synthesis step) blocks the metabolic flux through GGPP to tanshinone, switching GGPP to taxol synthesis. Agrobacterium rhizogenes mediated transformation using CRISPR/Cas9 generated three homozygous and eight chimeric mutants from 26 independent transgenic hairy root lines of Salvia. Metabolomics analysis revealed zero tanshinone accumulation in homozygous mutants and decreased percentage in chimeric mutants.

Prospective Applications of CRISPR System

CRISPR/Cas9 technology is advancing at an unprecedented pace. Most of the research done so far include gene knockout or gene silencing mechanisms via NHEJ, which is not precise and most prevailing mechanism. Gene knock-in or gene replacement strategies that follow targeted mutagenesis via HDR evidenced promising results in mammalian and plant cells. Homology driven repair was a difficult task earlier in plants because of low efficiency and inefficient delivery of homologous donor sequences into transfected plant cells. Multiple approaches are used for efficient homology directed repair mechanism and successful results have been reported. Genomic studies in woody plants are challenging because of the long vegetative periods, low genetic transformation efficiency and limited mutants. reported the disruption of site-specific endogenous phytoene desaturase gene (PtoPDS) in Populus tomentosa Carr. via. Homoallelic and heteroallelic pds mutants were detected in first generation. CRISPR/Cas9 has also been applied to lower members of kingdom Plantae like algae, bryophytes, pteridophytes, etc. Liverworts emerge as model species for studying land plant evolution. Molecular genetics of Marchantia polymorpha L. is studied by the application of CRISPR/cas9 targeted mutagenesis. Beyond genome editing, CRISPR/Cas9 technology is widely developing and used for various other purposes to understand functional genomics and molecular biology. The current focus is on loss-of-function and gain-of-function analysis of individual genes and identification of gene modules and genetic expression. Figure 6 represents the expanding footprints of CRISPR/Cas9 system of which many are yet to be tested in plants.

CRISPR has replaced the RNA interference (RNAi) gene silencing technology for efficient and precise gene knock down. It has overcome various limitations of RNAi technology, such as incomplete loss-of-function analysis and extensive off-target activities. With the development of simultaneous expression of multiple guide RNAs (sgRNAs), CRISPR/Cas9 system allows, “multiplex genome editing.” Multiplex genome-editing acts as a powerful tool for reducing genetic redundancy in paralogous sequences by creating multiplex gene knockouts. It has also been used to create chromosomal deletions from multiple DNA base pairs in Arabidopsis, Nicotiana benthamiana etc.

Gene Expression Regulation

Manipulating the genome of the target cells is another well-known CRISPR/Cas9 application. Repurposing CRISPR/Cas9 gene editing to gene expression regulation is known as CRISPR interference (CRISPRi). CRISPR interference involves either activation or repression of the gene expression. The establishment of CRISPR/Cas9 as gene regulatory machinery came up majorly from experimental studies on intracellular pathogen Francisella novicida. FTN-0757 gene expresses the virulence factor that represses the production of a bacterial lipoprotein (BLP). FTN-0757 is further examined as a type II Cas9 protein that in association with tracrRNA inactivate BLP expression in Francisella novicida. tracrRNA has an imperfect complementarity to BLP messenger, which requires Cas9 and a small CRISPR-Cas-associated RNA (scaRNA) for BLP mRNA degradation. A number of excellent reviews give the detailed information on principles of gene regulation by CRISPR/Cas system including.

Targeted regulation of gene expression provides interesting insights into the plant genome as well. The ectopic gene expression regulation provides important information for gene functioning and can also be applied to develop regulatory circuits for synthetic biology applications. Precise manipulation of the desired gene expression by repression or activation can elucidate the function of individual genes and their role in complex developmental processes. Gene expression regulation depends on the type of inducible or repressible promoters and the chemical or physical treatments for promoter activation and repression. Simultaneous multigene repression in plants was evaluated by. A synthetic repressor system (pCo-dCas9-3X- SRDX) was designed and tested on Arabidopsis cleavage stimulating factor 64 (AtCSTF64) gene and on non-protein coding genes (redundant microRNAs- miR159A and miR159B). The multigene gRNA designed against these genes were constructed into a T-DNA cassette harboring pCo-dCas9-3X (SRDX) pUBQ10 control. The transcript levels were reduced approximately by 60% as compared to control among the three independent transgenic lines. Similarly, the transcript levels were reduced to 50% and more in transgenic lines expressing miR159A and miR159B targeting construct.

Live Cell Imaging

Plant chromosomes are highly organized and compact structures. The spatiotemporal organization of plant genome determines the regulatory characteristics of various cell functions such as DNA replication and repair, transcription and cell death. Studies analyzing subcellular localization of genes and change in chromosomal structures provide insights into genome regulation and the systemic regulation of coding and non-coding genes during development. In vivo visualization of the defined DNA sequences is done prior by fluorescent in situ hybridization (FISH) but CRISPR imaging has overcome various issues related to FISH such as its inability to visualize dynamic processes and the requirement of fixed tissue samples. FISH also requires the cell fixation and DNA denaturation step which may alter the chromatin structure. CRISPR/Cas9 technology is customized with the introduction of Cas9 variant known as “dead Cas9” (dCas9). dCas9 is a catalytically inactive form of the nuclease (point mutation in either of the two catalytic domains, HNH and RuvC) that fuses with general transcription factors to its C-termini (Figure 7). dCas9 has the ability to bind to specific target DNA guided by sgRNA and allows direct imaging and manipulation of transcription without altering the DNA sequence. developed a CRISPR-dCas9 based cell imaging technique based on site directed mutagenesis of two Cas9 orthologs derived from Streptococcus pyrogens (Sp-dCas9) and Staphylococcus aureus (Sa-dCas9) followed by fusion of multiple copies of fluorescence proteins to the C-terminal end of each dCas9 variant. The use of dCas9 to inhibit gene expression is referred as CRISPR interference (CRISPRi). It is also used to deliver specific cargos and effector proteins to targeted genomic loci for transcriptional gene regulation. dCas9 has also being utilized to recruit transcriptional activators to the target promoter. Gene activation and repression in plants is still advancing with positive results reported in Nicotiana benthamiana and A. thaliana. This new Cas9 based system can further be employed to control the spatiotemporal patterns of gene expression in plants and modulating life cycles of various economically useful crops.

Generation of Mutant Libraries

A genomic library is an indispensable tool to identify gene function by assessing the cellular phenotypes of loss of function mutants. Progression of genetic mutant libraries has simplified the genomic explication of gene function in multiple organisms. Genetic perturbations can be achieved via conventional approaches like altering the copy number of the gene, mRNA or protein; use of chemical mutagens; irradiation; or random integration of foreign DNAs. cDNA libraries for gain-of-function mutations and short interfering (si)RNA libraries for loss-of-function mutations are considered as high-throughput screening approaches but have various drawbacks like lack of control of over expression levels and obstinate downstream analysis due to mutation at multiple loci. Now CRISPR/Cas9 is repurposed to enable high throughput sequence screening. Functional screening is generally done in two formats- arrayed and pooled. Various publications illustrate the role of CRISPR/Cas9 technology in screening. The arrayed format is a one gene per well-analyzing tool. Individual reagents are arranged in multiwell plates with a single reagent per well. Since each reagent is prepared separately, this method is expensive and time-consuming but allows investigation of a wider range of cellular phenotypes. Pooled libraries are single preparations of many different plasmids. These screens are less expensive and labor intensive.

DNA Free Modifications of Plant Genome

Cas9 edited crops are assumed to cross many hurdles and issues to be classified as genetically modified crops. Generally, CRISPR/Cas9 DNA constructs are delivered into plant cells by Agrobacterium-mediated infiltration, particle bombardment and protoplast transfection. The Agrobacterium-mediated method is more popular because it has a propensity to insert single or a low copy number of transgenes and does not require an expensive particle gun apparatus. However, the extra DNA delivered along the gRNA, Cas9 and selectable marker genes frequently integrate into the plant genome and may cause side effects like gene disruption, plant mosaicism and off target disruptions. Foreign DNA molecules can further integrate into the targeted DSB sites, lessens the efficiency of gene editing and gene insertion.

To alleviate the disadvantages of plasmid based expression of Cas9/gRNA; efficient DNA-free genome editing is adopted which uses Cas9 ribonucleoproteins (RNPs). Cas9 RNPs are in vitro pre-integrated Cas9 nucleases and gRNA that are delivered into plant cells as RNA molecules (Figure 8). Cas9 RNPs are equally efficient to plasmid based expression systems for gene knockouts and gene editing. These ribonucleoproteins can be delivered in mammalian cells via lipid-mediated electroporation or transfection techniques. However, in plants the presence of cell wall hinders these techniques. Therefore, RNPs are delivered in isolated plant protoplasts and successful results have been obtained in a variety of plants such as tobacco, Arabidopsis, lettuce, rice, Petunia, and wheat.

Similarly, have targeted the MLO-7 gene in grapes for developing resistance against powdery mildew disease and DIPM-1, DIPM-2, and DIPM-4 genes in apple for resistance against fire blight disease using CRISPR/Cas9 ribonucleoproteins. Commercially available recombinant Cas9 protein (160 kDa) was used and sgRNA was designed via CRISPR RGEN tools website for target specific sites having higher out of frame scores to achieve maximum knock out efficiency. Direct delivery of CRISPR RNPs in plant protoplast and efficient targeted mutagenesis with 0.1% and 0.5–0.69% indels (insertion or deletion) in targeted sites of MLO-7 and DIPM-1, 2, and 4 was reported respectively. But plant regeneration from protoplast is challenging for most of the cereal crops, mainly monocots. Therefore, DNA-free efficient genome editing has been done in multiple crops like rice, maize, wheat using CRISPR/Cas9 ribonucleoprotein complexes via particle bombardment in embryo cells. are the pioneers to report biolistic delivery of Cas9-gRNA RNP into immature maize embryo. Liguleless 1 (LIG) gene, Male fertility genes (MS26 and MS45) and Acetolactate synthase gene (ALS2) was targeted and mutation frequencies of Cas9/gRNA plasmid based system and Cas9 RNPs were evaluated. Mutation frequencies of plasmid based Cas9 system- 0.004, 0.020, 0.004, and 0.002% respectively for LIG, ALS2, MS26, and MS45 was remarkably low when compared to RNP delivery where the frequencies were 0.57, 0.45, 0.21, and 0.69 respectively. Finally, efficient delivery and high cleavage activity of RNPs was demonstrated.

CRISPR/Cas9 Opportunities and Concerns

Customizable sequence specific nucleases are a powerful tool for plant genome editing. Historically, mega nucleases, ZFNs, and TALENs have been SSNs of choice but the introduction of CRISPR/Cas9 system has revolutionized the genome editing technologies. The importance of this system lies in its relative ease of use, high precision, and low start-up cost. The most distinct feature of CRISPR technology, i.e., DNA cleavage recognition through Watson and Crick base pairing drastically simplifies the DNA targeting. The emergence of two RNA components (CRISPR RNA and trans activating CRISPR RNA) into sgRNA has further simplified the CRISPR/Cas system and enhanced reagent delivery. CRISPR/Cas system allows simultaneous targeting of multiple genomic loci due to the simplified engineering of target specificity. Moreover, CRISPR/Cas system can readily be engineered to Cas9 nickases, introducing single stranded breaks. Compared to zinc finger nickases and transcription activator-like effector nickases, Cas9 nickases have no residual nuclease activity and greatly alleviate the risk of off-target activity.

Advancements and characterization of new CRISPR effector proteins have broadened the range of biotechnological applications via CRISPR/Cas system. For example, dormancy in any cells such as cancer cells can be achieved using type VI C2c2 effector proteins. C2c2 can inhibit cell growth in vivo when primed with cognate RNA. The potential of an inactive programmable RNA- binding protein (dC2c2) can be used to track and visualize specific RNAs and to modulate the function of effector modules that can be used for the construction of synthetic regulatory circuits and large-scale screening. The continuous development and validation of new functional toolkits provide immense opportunities to activate an imprinted gene and gene expression. have developed a multifaceted toolkit consisting of Golden Gate and Gateway compatible vectors. They demonstrated the less explored multiplexing by expressing three independent gRNAs simultaneously in tobacco, rice, and Arabidopsis and successfully triggered or suppressed the expression of protein coding and non-coding genes. proposed a solution to gRNA mismatch and off-target editing by featuring the interaction between four different domains of Cas9. These domains increase the binding energy of Cas9 to targeted sequences up to mismatches, thus weakening these interactions would provide better results to improve off-target interactions. Major limitations of the CRISPR/Cas9 system include inefficient HDR to NHEJ ratio and very few simultaneous changes per cell. The frequent occurrence of non-target effects further hampers the use of this technology. One of the major drawbacks of Cas9 editing is mismatched cleavage when the gRNA mismatches a few bases. Many reports indicated the infrequency with which CRISPR cuts the non-targeted sequences.

Visionary Notions of this Technology

Research investigation in the past quadrennial has transcend genome editing tools ranging from targeted gene modifications to designing eIF4E resistance alleles which is a key player in virus resistance to alter genes to create multiple attributes like tolerance to abiotic and biotic stress in plants viz. drought tolerance, virus and disease resistance, enhanced nutritional, high yield crop and enhance shelf-life of the plants. CRISPR-Cas9 technology witnesses the future of versatile genome editing with robust and efficacious consequences. The forte of gene editing in plants including crops has been radically changed by CRISPR-Cas9 technology. Exploring the fundamental biology of plant development and stress response will facilitate in designing elite and superior crops. The CRISPR-Cas9 holds a very promising future in making designer plants by taking only the gene of interest from a wild type species and the gene is then directly interpolated at a precise location, which in turn opens many avenues for plant breeders for making designer plants. Various approaches are going to design plants in such a manner, which could withstand with all possible harsh challenges. The newly emerged CRISPR/Cas9 RNP system evaded the need to relay on target cell potential for Cas9 translation and its plausible meeting with gRNA.

CRISPR/Cas9 sequence specific nuclease editing is an effective approach to combat rice blast disease. OsERF922 gene in rice was targeted and 21 CRISPR-ERF922 induced mutants were identified from 50 T0 transgenic plants. Furthermore, the high throughput can be obtained by coalescence of cytidine deaminase enzyme with Cas9, which permits high-efficiency emendation of target codons in rice. dCas9 fusion with cytidine deaminase allows direct conversion of cytidine to uridine leading to a point mutation from C/G bp to T/A bp during replication in one of the daughter cells. Researches in the advancement of legendary technology are deliberately going on but one stubborn and constantly following pitfall related to off-targets in plants, which could be executed by doing whole genome sequencing. Many companies are also engaged in using this technology for the production of elite food and feed crops. The products, which are obtained by editing through CRISPR-Cas9, have no exogenous DNA and furthermore editing can be done in such a way, which abides by all the rules and regulations that are complaisant to withstand against Genetically Modified issues and can get an easy approval by the Department of Agriculture (USDA). In conclusion, CRISPR-Cas9 technology boasts of a promising future in making the desired mutation in plants because it has transformed and metamorphosed our potential to modify and regulate prokaryotic and eukaryotic genomes. The prevalent use of this technology will surely expedite its pace.

Author Contributions

LA has written the manuscript under the supervision and drafting of AN. The review was finally edited and submitted by AN.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 136

  1. 1.

    Abudayyeh O. O. Gootenberg J. S. Konermann S. Joung J. Slaymaker I. M. Cox D. B. (2016 ). C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353 557–566.

    Not in our library10.1126/science.aaf5573

  2. 2.

    Agrotis A. Ketteler R. (2015 ). A new age in functional genomics using CRISPR/Cas9 in arrayed library screening. Front. Genet. 6:300.

    Not in our library10.3389/fgene.2015.00300

  3. 3.

    Ahloowalia B. S. Maluszynski M. (2001 ). Induced mutations- A new paradigm in plant breeding. Euphytica 118 167–173.

    Not in our library10.1023/a:1004162323428

  4. 4.

    Ainley W. M. Sastry-Dent L. Welter M. E. Murray M. G. Zeitler B. Amora R. (2013 ). Trait stacking via targeted genome editing. Plant Biotechnol. J. 11 1126–1134.

    Not in our library10.1111/pbi.12107

  5. 5.

    Alagoz Y. Gurkok T. Zhang B. Unver T. (2016 ). Manipulating the biosynthesis of bioactive compound alkaloids for next-generation metabolic engineering in opium poppy using CRISPR-Cas 9 genome editing technology. Sci. Rep. 6 309–310.

    Not in our library10.1038/srep30910

  6. 6.
  7. 7.

    Amitai G. Sorek R. (2016 ). CRISPR-Cas adaptation: insights into the mechanism of action. Nat. Rev. Microbiol. 14 67–76.

    Not in our library10.1038/nrmicro.2015.14

  8. 8.
  9. 9.

    Baltes N. J. Gil-Humanes J. Cermak T. Atkins P. A. Voytas D. F. (2014 ). DNA replicons for plant genome engineering. Plant Cell 26 151–163.

    Not in our library10.1105/tpc.113.119792

  10. 10.

    Barrangou R. Fremaux C. Deveau H. Richards M. Boyaval P. Moineau S. (2007 ). CRISPR provides acquired resistance against viruses in prokaryotes. Science 315 1709–1712.

    Not in our library10.1126/science.1138140

  11. 11.

    Bastet A. Robaglia C. Gallois J. C. (2017 ). eIF4E Resistance: Natural Variation Should Guide Gene Editing. Trends Plant Sci. 17 S1360–S1385.

    Not in our library10.1016/j.tplants.2017.01.008

  12. 12.

    Bikard D. Jiang W. Samai P. Hochschild A. Zhang F. Marraffini L. A. (2013 ). Programmable repression and activation of bacterial gene expression using an engineered CRISPR–Cas system. Nucleic Acids Res. 41 7429–7437.

    Not in our library10.1093/nar/gkt520

  13. 13.

    Bikard D. Marraffini L. A. (2013 ). Control of gene expression by CRISPR-Cas systems. F1000Prime Rep. 5:47.

    Not in our library10.12703/p5-47

  14. 14.

    Boch J. Scholze H. Schornack S. Landgraf A. Hahn S. Kay S. (2009 ). Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326 1509–1512.

    Not in our library10.1126/science.1178811

  15. 15.

    Boettiger A. N. Bintu B. Moffitt J. R. Wang S. Beliveau B. J. Fudenberg G. (2016 ). Super-resolution imaging reveals distinct chromatin folding for different epigenetic states. Nature 529 418–422.

    Not in our library10.1038/nature16496

  16. 16.

    Bolotin A. Quinquis B. Sorokin A. Ehrlich S. D. (2005 ). Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extra-chromosomal origin. Microbiology 151 2551–2561.

    Not in our library10.1099/mic.0.28048-0

  17. 17.

    Bortesi L. Fischer R. (2015 ). The CRISPR/Cas9 system for plant genome editing and beyond. Biotechnol. Adv. 33 41–52.

    Not in our library10.1016/j.biotechadv.2014.12.006

  18. 18.

    Brooks C. Nekrasov V. Lippman Z. B. Van Eck J. (2014 ). Efficient gene editing in tomato in the first generation using the clustered regularly interspaced short palindromic repeats/CRISPR-associated9 system. Plant Physiol. 166 1292–1297.

    Not in our library10.1104/pp.114.247577

  19. 19.

    Brouns S. J. Jore M. M. Lundgren M. Westra E. R. Slijkhuis R. J. Snijders A. P. (2008 ). Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321 960–964.

    Not in our library10.1126/science.1159689

  20. 20.
  21. 21.

    Chandrasekaran J. Brumin M. Wolf D. Leibman D. Klap C. Pearlsman M. (2016 ). Development of broad virus resistance in non-transgenic cucumber using CRISPR/Cas9 technology. Mol. Plant Pathol. 17 1140–1153.

    Not in our library10.1111/mpp.12375

  22. 22.
  23. 23.

    Chen X. Lu X. Shu N. Wang S. Wang J. Wang D. (2017 ). Targeted mutagenesis in cotton (Gossypium hirsutum L.) using the CRISPR/Cas9 system. Sci. Rep. 7 44304–44311.

    Not in our library10.1038/srep44304

  24. 24.

    Choi K. R. Lee S. Y. (2016 ). CRISPR technologies for bacterial systems: current achievements and future directions. Biotechnol. Adv. 34 1180–1209.

    Not in our library10.1016/j.biotechadv.2016.08.002

  25. 25.

    Christian M. Cermak T. Doyle E. L. Schmidt C. Zhang F. Hummel A. (2010 ). Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186 757–761.

    Not in our library10.1534/genetics.110.120717

  26. 26.

    Collonnier C. DebasT A. G. Maclot F. Mara K. Charlot F. Nogue F. (2017 ). Towards mastering CRISPR-induced gene knock-in in plants: survey of key features and focus on the model Physcomitrella patens. Methods 121-122 103–117.

    Not in our library10.1016/j.ymeth.2017.04.024

  27. 27.

    Cong L. Ran F. A. Cox D. Lin S. Barretto R. Habib N. (2013 ). Multiplex genome engineering using CRISPR/Cas systems. Science 339 819–823.

    Not in our library10.1126/science.1231143

  28. 28.

    Curtin S. J. Zhang F. Sander J. D. Haun W. J. Starker C. Baltes N. J. (2011 ). Targeted mutagenesis of duplicated genes in soybean with zinc-finger nucleases. Plant Physiol. 156 466–473.

    Not in our library10.1104/pp.111.172981

  29. 29.

    Deltcheva E. Chylinski K. Sharma C. M. Gonzales K. Chao Y. Pirzada Z. A. (2011 ). CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471 602–607.

    Not in our library10.1038/nature09886

  30. 30.

    Dominguez A. A. Lim W. A. Qi L. S. (2016 ). Beyond editing: repurposing CRISPR–Cas9 for precision genome regulation and interrogation. Nat. Rev. Mol. Cell Biol. 17 5–15.

    Not in our library10.1038/nrm.2015.2

  31. 31.

    Esvelt K. M. Mali P. Braff J. L. Moosburner M. Yaung S. J. Church G. M. (2013 ). Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat. Methods 10 1116–1121.

    Not in our library10.1038/nmeth.2681

  32. 32.
  33. 33.

    Fauser F. Schiml S. Puchta H. (2014 ). Both CRISPR/Cas based nucleases and nickases can be used efficiently for genome engineering in Arabidopsis thaliana. Plant J. 79 348–359.

    Not in our library10.1111/tpj.12554

  34. 34.

    Feng Z. Mao Y. Xu N. Zhang B. Wei P. Yang D. L. (2014 ). Multigeneration analysis reveals the inheritance, specificity, and patterns of CRISPR/Cas-induced gene modifications in Arabidopsis. Proc. Natl. Acad. Sci. U.S.A. 111 4632–4637.

    Not in our library10.1073/pnas.1400822111

  35. 35.

    Feng Z. Zhang B. Ding W. Liu X. Yang D. L. Wei P. (2013 ). Efficient genome editing in plants using a CRISPR/Cas system. Cell Res. 23 1229–1232.

    Not in our library10.1038/cr.2013.114

  36. 36.

    Fu Y. Foden J. A. Khayter C. Maeder M. L. Reyon D. Joung J. K. (2013 ). High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31 822–826.

    Not in our library10.1038/nbt.2623

  37. 37.

    Gaj T. Gersbach C. A. Barbas C. F. (2013 ). ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 31 397–405.

    Not in our library10.1016/j.tibtech.2013.04.004

  38. 38.

    Gao J. Wang G. Ma S. Xie X. Wu X. Zhang X. (2015 ). CRISPR/Cas9 mediated targeted mutaGenesis in Nicotiana tabacum. Plant Mol. Biol. 87 99–110.

    Not in our library10.1007/s11103-014-0263-0

  39. 39.

    Gao Y. Zhao Y. (2014 ). Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro and in vivo for CRISPR-mediated genome editing. J. Int. Plant Biol. 56 343–349.

    Not in our library10.1111/jipb.12152

  40. 40.

    Garneau J. E. Dupuis M. E. Villion M. Romero D. A. Barrangou R. Boyaval P. (2010 ). The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468 67–71.

    Not in our library10.1038/nature09523

All 136 references

Cited by papers we hold 5

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.